Hepalink Partners with Yongtai for U.S. Gabapentin Market
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H (HK:9989) has released an update.Don't Miss Our New Year's Offers:Discover the latest ...
C&EN23d
Lonza to exit capsule business
Wolfgang Wienand, who joined Lonza as CEO in July, has begun to put his stamp on the Swiss drug services company. Lonza announced at an investor event that it plans to divest its Capsules and ...